Malignant peritoneal cytology and increased mortality risk in stage I non-endometrioid endometrial cancer
- 18 July 2020
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 159 (1) , 43-51
Abstract
No abstract availableKeywords
Funding Information
- Ensign Endowment for Gynecologic Cancer Research
This publication has 37 references indexed in Scilit:
- Does Positive Peritoneal Cytology Not Affect the Prognosis for Stage I Uterine Endometrial Cancer?International Journal of Gynecological Cancer, 2014
- Integrated genomic characterization of endometrial carcinomaNature, 2013
- Positive peritoneal cytology is an independent risk-factor in early stage endometrial cancerGynecologic Oncology, 2013
- Comparative Effectiveness Research in Oncology Methodology: Observational DataJournal of Clinical Oncology, 2012
- Effect of hysteroscopy on the peritoneal dissemination of endometrial cancer cells: a meta-analysisFertility and Sterility, 2011
- Intraperitoneal Dissemination of Endometrial Cancer Cells After HysteroscopyInternational Journal of Gynecological Cancer, 2010
- Positive peritoneal cytology and its prognostic value in endometrioid adenocancer confined to the uterusOncologie, 2008
- The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancerGynecologic Oncology, 2007
- Is peritoneal cytology a prognostic factor of endometrial cancer confined to the uterus?Gynecologic Oncology, 2006
- Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trialsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1997